Phase I clinical trial of pharmacokinetics and safety comparison between the generic and the original bevacizumab

Ren Xiuhua, Yu Hengyi, Fang Yinian, Zhang Donglin, Chen Qian,

PDF(738 KB)
PDF(738 KB)
Adverse Drug Reactions Journal ›› 2022, Vol. 24 ›› Issue (6) : 300-307. DOI: 10.3760/cma.j.cn114015-20220218-00138

Phase I clinical trial of pharmacokinetics and safety comparison between the generic and the original bevacizumab

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 24(6): 300-307 https://doi.org/10.3760/cma.j.cn114015-20220218-00138

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(738 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉